國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Advancing gene fusion detection towa...

Koo, Kevin M.

Advancing gene fusion detection towards personalized cancer nanodiagnostics

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Advancing gene fusion detection towards personalized cancer nanodiagnosticsby Kevin M. Koo.
作者:	Koo, Kevin M.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	xiii, 102 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	ProstateCancer
電子資源:	https://doi.org/10.1007/978-3-030-31000-4
ISBN:	9783030310004$q(electronic bk.)

Advancing gene fusion detection towards personalized cancer nanodiagnostics
Koo, Kevin M.

Advancing gene fusion detection towards personalized cancer nanodiagnostics[electronic resource] /by Kevin M. Koo. - Cham :Springer International Publishing :2019. - xiii, 102 p. :ill., digital ;24 cm. - Springer theses,2190-5053. - Springer theses..

Unifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer (PCa) Management -- Colorimetric Gene Fusion Diagnostics for Visual Binary Readout -- Label -Free Surface-Enhanced Raman Scattering Detection System for Clinical Biomarker Targets -- Amplification-Free Electrochemical RNA Biomarker Sensing -- Simultaneous Analysis of Multiple Biomarkers via High-Throughput Parallel Profiling.

This book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development.

ISBN: 9783030310004$q(electronic bk.)

Standard No.: 10.1007/978-3-030-31000-4doiSubjects--Topical Terms:

851885
Prostate
--Cancer

LC Class. No.: RC899 / .K665 2019

Dewey Class. No.: 616.99463075

Advancing gene fusion detection towards personalized cancer nanodiagnostics
LDR:02263nmm a2200337 a 4500 001 566269
003 DE-He213
005 20191217165531.0
006 m d
007 cr nn 008maaau
008 200429s2019 gw s 0 eng d
020 $a 9783030310004$q(electronic bk.)
020 $a 9783030309992$q(paper)
024 7 $a 10.1007/978-3-030-31000-4 $2 doi
035 $a 978-3-030-31000-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC899 $b .K665 2019
072 7 $a MQW $2 bicssc
072 7 $a MED003040 $2 bisacsh
072 7 $a MQW $2 thema
082 0 4 $a 616.99463075 $2 23
090 $a RC899 $b .K82 2019
100 1 $a Koo, Kevin M. $3 851884
245 1 0 $a Advancing gene fusion detection towards personalized cancer nanodiagnostics $h [electronic resource] / $c by Kevin M. Koo.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xiii, 102 p. : $b ill., digital ; $c 24 cm.
490 1 $a Springer theses, $x 2190-5053
505 0 $a Unifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer (PCa) Management -- Colorimetric Gene Fusion Diagnostics for Visual Binary Readout -- Label -Free Surface-Enhanced Raman Scattering Detection System for Clinical Biomarker Targets -- Amplification-Free Electrochemical RNA Biomarker Sensing -- Simultaneous Analysis of Multiple Biomarkers via High-Throughput Parallel Profiling.
520 $a This book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development.
650 0 $a Prostate $x Cancer $x Diagnosis $x Technological innovations. $3 851885
650 0 $a Biochemical markers. $3 195446
650 1 4 $a Biomedical Engineering/Biotechnology. $3 730838
650 2 4 $a Nanotechnology. $3 193873
650 2 4 $a Biomedical Engineering and Bioengineering. $3 826326
650 2 4 $a Cancer Research. $3 273660
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Springer theses. $3 557607
856 4 0 $u https://doi.org/10.1007/978-3-030-31000-4
950 $a Biomedical and Life Sciences (Springer-11642)